Professor of Medicine
Campus mail:
03119 Hosp South, Suite 03107, Room 03125, Durham, NC 27710
Phone:
(919) 684-3262
My research interests include metabolic liver disease, particularly obesity-related liver disease and its association with complications of the insulin resistance syndrome. I am interested in studying the clinical, environmental, and genetic risk factors for nonalcoholic fatty liver disease, new therapeutic options for treatment, and evaluating the impact of NAFLD from a public health perspective.
Education and Training
- University Missouri Kansas City, M.D. 1992
- Mayo School of Health Sciences, Medical Resident, Medicine
- Mayo School of Health Sciences, Fellow in Gastroenterology, Medicine
Selected Grants and Awards
- Gilead 384-1943
- Gilead 384-1944
- Madrigal MGL-3196-11
- Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN)
- ARMOR
- Celgene CC-90001 NASH-001
- NovoNordisk 4492
- Duke CTSA (KL2)
- Duke CTSA (TL1)
- Target-NASH
- Intercept 747-303
- Genentech GC41003
- Durect DUR-928
- FALCON 1
- FALCON 2
- Inventiva IVA337
- NGM282 18-0108
- Genfit GFT505-315-1 NASH
- STAMP - STudy of AMP Kinase Activator
- Novartis LJC242A2201J
- Intercept 747-304
- Galectin GI-026
- Enyo EYP001-202
- Allergan 301-002
- Allergan 201-002
- Progenity PRO-121-NAFLD
- Enanta EDP 305-101
- Conatus IDN 6556-17
- Gilead 454-4378
- Boehringer BI 1467335
- Gilead 384-1497
- Genetic and Epigenetic Markers of Progressive Nonalcoholic Fatty Liver Disease
- Conatus IDN 6556-14
- TOBIRA 652-2-203
- Madrigal MGL-3196-05
- Conatus IDN-6556-12
- BMS MB130-045
- NGM 15-0105
- Immuron IMM-124E
- NASH Clinical Research Network
- Shire SHP626-201
- Gilead 402-1852
- GILEAD 426-3989
- Intercept 747-117
- ARREST - GALMED
- Intercept 747-209
- Cirius EMMINENCE
- Exalenz - CSPH-EX-0414
- Glympse Bio NASH
- Acoustic Radiation Force Based Hepatic Elasticity Quantification and Imaging
- ARI-3037MO-006
- Impact of Fructose on Metabolism, Energy Homeostasis and MR biomarkers in NAFLD
- Synageva BioPharma LAL-CSS01
- Development and clinical validation of a clinical diagnostic/prognostic laboratory test for liver disease
- Characterizing Alcohol's Effects on Repair of Liver Injury
- Hyperinsulimia and Insulin Resistance in Nonalcoholic Fatty Liver Disease